Moneycontrol PRO
Open App

business

Clearances main worry, says Serum head on dengue antibody

Serum Chief executive officer Adar Poonawalla says the company has entered into an exclusive agreement with US-based Visterra for developing a dengue antibody.

LATEST VIDEOS

Watch More →

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Sections
ISO 27001 - BSI Assurance Mark